Hirohara Masayoshi, Tsuchida Hiroyoshi, Uemura Shuichiro, Ozaki Yuhi, Saida Shin, Koike Nobusada
Division of Surgery, Hachioji Digestive Disease Hospital, 177-3 Yorozucho, Hachioji, Tokyo, 192-0903, Japan.
Surg Endosc. 2025 Sep 19. doi: 10.1007/s00464-025-12262-7.
Occult hernias, defined as asymptomatic hernias not detectable on physical examination, are identified intraoperatively in up to 22% of patients undergoing laparoscopic inguinal hernia repair. While treatment may prevent future symptomatic herniation in approximately 21-29% of patients, the risk of complications on the occult hernia side remains unclear, especially when using the transabdominal preperitoneal (TAPP) approach, which has been widely adopted.
We retrospectively analyzed 350 patients who underwent elective TAPP repair between January 2020 and December 2024. Patients were divided into two groups: the occult hernia group (n = 51), who underwent bilateral repair, including occult hernia treatment, and the non-occult hernia group (n = 299), who received unilateral repair without occult hernia identification. Postoperative complications were assessed at the first outpatient visit (median, 19 days postoperatively), compared between groups, and analyzed by occult and symptomatic sides.
The overall complication rates, defined as the occurrence of seroma; surgical site infection; and acute postoperative inguinal pain (APIP), which is pain requiring analgesics, were 13.7% and 16.4% in the occult and non-occult hernia groups, respectively (p = 0.84). On the occult hernia side (n = 51), the complication rate (seroma and APIP) was significantly lower than on the symptomatic side (n = 350) (2.0% vs. 12.3%, p = 0.03), with only one seroma and no APIP observed.
Based on prior reports, the number needed to treat to prevent one symptomatic hernia was estimated to be 4.6 (95% credible interval: 3.1-7.3), while the number needed to harm for occult hernia side complications was 51. Treatment of occult hernias during TAPP repair was associated with a low incidence of complications on the occult hernia side and a favorable benefit-to-risk balance. These findings support the safety and rationale for treating occult hernias in TAPP procedures.
隐匿性疝定义为体格检查时无法检测到的无症状疝,在接受腹腔镜腹股沟疝修补术的患者中,高达22%的患者在术中被发现存在隐匿性疝。虽然治疗可能会预防约21%-29%的患者未来出现症状性疝,但隐匿性疝一侧的并发症风险仍不明确,尤其是在广泛采用的经腹腹膜前(TAPP)手术方式中。
我们回顾性分析了2020年1月至2024年12月期间接受择期TAPP修补术的350例患者。患者分为两组:隐匿性疝组(n = 51),接受双侧修补,包括隐匿性疝治疗;非隐匿性疝组(n = 299),接受单侧修补,未发现隐匿性疝。在首次门诊就诊时(中位数为术后19天)评估术后并发症,比较两组情况,并按隐匿性疝侧和有症状侧进行分析。
总体并发症发生率定义为血清肿、手术部位感染以及急性术后腹股沟疼痛(APIP,即需要使用镇痛药的疼痛)的发生情况,隐匿性疝组和非隐匿性疝组分别为13.7%和16.4%(p = 0.84)。在隐匿性疝侧(n = 51),并发症发生率(血清肿和APIP)显著低于有症状侧(n = 350)(2.0%对12.3%,p = 0.03),仅观察到1例血清肿,未出现APIP。
根据既往报告,预防1例症状性疝所需治疗的患者数估计为4.6(95%可信区间:3.1-7.3),而隐匿性疝侧出现并发症所需伤害的患者数为51。TAPP修补术中治疗隐匿性疝与隐匿性疝侧并发症发生率低以及良好的风险效益平衡相关。这些发现支持了在TAPP手术中治疗隐匿性疝的安全性和合理性。